InsidersTradesSigma
Track the Hangzhou Diagens Biotechnology Co., Ltd. - B stock price and the full directors' dealings record of the company, a publicly traded company based in Hong Kong. Shares are quoted on the HK market, under the oversight of HKEX. Operating in the Health Care sector, Hangzhou Diagens Biotechnology Co., Ltd. - B has logged 1 public disclosures. Market capitalisation: €27.5bn. The latest transaction was reported on 14 April 2026 (Other). Among the most active insiders: SONG Ning. Every trade is openly available.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
杭州迪安诊断技术股份有限公司是一家专注于开发生物制药解决方案的公司。该公司在香港证券交易所上市。